JPAG Symposium: Advanced Dissolution
DATE OF EVENT: Thursday 21st January 2027
EVENT LINK: https://www.jpag.org/199
VENUE: Royal Society of Chemistry, London
Burlington House, Piccadilly, London W1J 0BA
VENUE LINK: www.rsc.org/locations-contacts/
ORGANISED BY: Joint Pharmaceutical Analysis Group
WEB LINK: https://www.jpag.org/
SPONSORS: Royal Pharmaceutical Society and Royal Society of Chemistry
CONTACT: Hon Events Secretary JPAG, events@jpag.org
This event brings together scientists, analysts, and industry colleagues for a focused, one day exploration of advanced dissolution and its growing role in modern pharmaceutical development. It is a follow on from the Fundamentals event held in October 2025. As formulations become more complex and regulatory expectations evolve, dissolution has shifted from a simple quality test to a powerful, mechanistic tool for understanding drug performance.
This seminar creates space for sharing experiences, practical insight alongside open discussions. During the day, we aim to highlight new approaches, identify emerging challenges, and discuss the analytical strategies that will shape the next generation of oral medicines. The challenge for us all is: can a single test be sensitive enough to predict changes that may be of clinical relevance, whilst being robust enough to satisfy the needs of a quality control environment?
Response from potential speakers has been fantastic and the programme is now complete. We are now looking for poster presenters on topics such as:
o Biorelevant dissolution media
o Non-pharmacopoeial apparatus and modified setups
o Dissolution–permeation or dissolution–absorption models
o In vitro–in vivo correlation (IVIVC) driven dissolution
o Automation, high throughput, and real time analytics
o Dissolution tailored for novel formulations
This symposium should be attractive to scientists working in research and development, quality control, regulatory, pharmacopoeias and academia. In addition senior managers will benefit from attending.
SPEAKERS:
Dr Hannah Batchelor - Strathclyde Institute of Pharmacy and Biomedical Sciences
Dr James Butler - Consultant, formerly GlaxoSmithKline
Dr Paul Dickinson - Founder and Chief Scientist, Seda Pharmaceutical Development Services
Dr James Mann - AstraZeneca
Dr Laura Mason - Upperton Pharma Solutions
Marta Nawrocka - Pharmaron
Kieran Smith - Biowaived
Comments